Literature DB >> 26605317

Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report.

Lourdes Roca-Argente1, Jose-Luis Moll-Guillen1, Jordi Espí-Reig1, Marino Blanes-Julia1, Ana-María García-Martínez1, Conrad Pujol-Marco1, Julio Hernández-Jaras1.   

Abstract

Levamisole is illicitly employed as a cocaine adulterant. The consumption of levamisole-adulterated cocaine can provoke anti-neutrophil cytoplasmic antibody (ANCA)-associated syndromes. Patients carrying an HLAB27 allele are known to be at higher risk of developing agranulocytosis when treated with levamisole. Likewise, patients with ANCA-associated vasculitis (AAV) and internal organ involvement have typically been exposed to offending agents for prolonged periods of time, often on the order of years. Here, we report an unusual case of a patient in which kidney biopsy showed membranous glomerulonephritis with cellular crescents associated with levamisole-contaminated cocaine use.

Entities:  

Keywords:  Vasculitis; anti-neutrophil cytoplasmic antibody (ANCA); cocaine; glomerulonephritis; levamisole

Year:  2015        PMID: 26605317      PMCID: PMC4630559          DOI: 10.3978/j.issn.2305-5839.2015.10.29

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  14 in total

Review 1.  Cutaneous vasculopathy associated with levamisole-adulterated cocaine.

Authors:  Huy Tran; Debbie Tan; Thomas P Marnejon
Journal:  Clin Med Res       Date:  2012-06-21

2.  Levamisole-induced thrombosis: literature review and pertinent laboratory findings.

Authors:  Kachiu C Lee; Keliegh Culpepper; Margaret Kessler
Journal:  J Am Acad Dermatol       Date:  2011-10       Impact factor: 11.527

3.  Systemic complications of levamisole toxicity.

Authors:  Kachiu Cecilia Lee; Barry Ladizinski; F N U Nutan
Journal:  J Am Acad Dermatol       Date:  2012-10       Impact factor: 11.527

4.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease.

Authors:  Martina M McGrath; Tamara Isakova; Helmut G Rennke; Ann M Mottola; Karen A Laliberte; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

Review 5.  Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement.

Authors:  Angela Wolford; Thomas S McDonald; Heather Eng; Steven Hansel; Yue Chen; Jonathan Bauman; Raman Sharma; Amit S Kalgutkar
Journal:  Drug Metab Dispos       Date:  2012-03-05       Impact factor: 3.922

6.  Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children.

Authors:  F Rongioletti; L Ghio; F Ginevri; D Bleidl; S Rinaldi; A Edefonti; C Gambini; G Rizzoni; A Rebora
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

7.  A boy with cutaneous necrosis occurring during treatment with levamisole.

Authors:  J Powell; H Grech; J Holder
Journal:  Clin Exp Dermatol       Date:  2002-01       Impact factor: 3.470

8.  Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge.

Authors:  Kachiu C Lee; Barry Ladizinski; Daniel G Federman
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

9.  Complications of cancer immunotherapy with levamisole.

Authors:  D R Parkinson; P O Cano; L M Jerry; A Capek; H R Shibata; P W Mansell; M G Lewis; G Marquis
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

10.  Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases.

Authors:  Adam Q Carlson; Delphine S Tuot; Kuang-Yu Jen; Brad Butcher; Jonathan Graf; Ramin Sam; John B Imboden
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

View more
  2 in total

1.  A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.

Authors:  Carmelo Carmona-Rivera; Monica M Purmalek; Erica Moore; Meryl Waldman; Peter J Walter; H Martin Garraffo; Karran A Phillips; Kenzie L Preston; Jonathan Graf; Mariana J Kaplan; Peter C Grayson
Journal:  JCI Insight       Date:  2017-02-09

Review 2.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.